Literature DB >> 29990854

Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling.

Xiaojie Li1, Jianya He1, Miaomiao Shao1, Bai Cui2, Fei Peng2, Jiao Li1, Yan Ran1, Dong Jin1, Jing Kong1, Jinming Chang2, Liqiang Duan2, Xuesong Yang3, Yong Luo4, Yao Lu5, Bingcheng Lin5, Tingjiao Liu6.   

Abstract

The invasion front of oral squamous cell carcinoma (OSCC) harbors the most aggressive cells of the tumor and is critical for cancer invasion and metastasis. MicroRNAs (miRNAs) play important roles in OSCC progression. In this study, we modelled the OSCC invasion front on a microfluidic chip, and investigated differences in miRNA profiles between cells in the invasion front and those in the tumor mass by small RNA sequencing. We found that miR-218-5p was downregulated in invasion front cells and negatively regulates OSCC invasiveness by targeting the CD44-ROCK pathway. Thus, miR-218-5p may serve as a useful therapeutic target for OSCC. Moreover, invasion front cell isolation based-on microfluidic technology provided a useful strategy for cancer invasion study.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CD44; Invasion; Microfluidic chip; OSCC; ROCK; miR-218-5p

Mesh:

Substances:

Year:  2018        PMID: 29990854     DOI: 10.1016/j.biopha.2018.06.151

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

1.  Multiplexed profiling of single-cell extracellular vesicles secretion.

Authors:  Yahui Ji; Dongyuan Qi; Linmei Li; Haoran Su; Xiaojie Li; Yong Luo; Bo Sun; Fuyin Zhang; Bingcheng Lin; Tingjiao Liu; Yao Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-11       Impact factor: 11.205

2.  Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma.

Authors:  Zifeng Cui; Qiwen Song; Yanping Chen; Kaicheng Yang
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-02-03       Impact factor: 1.648

3.  ARPP-19 Mediates Herceptin Resistance via Regulation of CD44 in Gastric Cancer.

Authors:  Xiang Gao; Changwen Lu; Changyu Chen; Kang Sun; Qixin Liang; Jianfeng Shuai; Xiaoming Wang; Yuxing Xu
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

4.  Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis.

Authors:  Guanghui Jia; Yalei Wang; Yali Yu; Zijun Li; Xiangyu Wang
Journal:  Oncol Rep       Date:  2020-07-20       Impact factor: 3.906

Review 5.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.

Authors:  Abdul Q Khan; Eiman I Ahmed; Noor R Elareer; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

Review 6.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

7.  The role of the miR1976/CD105/integrin αvβ6 axis in vaginitis induced by Escherichia coli infection in mice.

Authors:  Lisha Jiang; Lingling Zhang; Can Rui; Xia Liu; Zhiyuan Mao; Lina Yan; Ting Luan; Xinyan Wang; Ying Wu; Ping Li; Xin Zeng
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

8.  Changes in cytoarchitecture and mobility in B16F1 melanoma cells induced by 5-Br-2'-dU coincide with Rock2, miRNAs 138-5p and 455-3p reciprocal expressions.

Authors:  Esther Natalia Muñoz; Hernán Mauricio Rivera; Luis Alberto Gómez
Journal:  Biochem Biophys Rep       Date:  2021-06-11

9.  LncRNA SNHG12 regulates ox-LDL-induced endothelial cell injury by the miR-218-5p/IGF2 axis in atherosclerosis.

Authors:  Ping Mao; Xiaowei Liu; Yingzheng Wen; Lijiang Tang; Yimin Tang
Journal:  Cell Cycle       Date:  2021-07-27       Impact factor: 5.173

10.  MicroRNA-299-3p/FOXP4 Axis Regulates the Proliferation and Migration of Oral Squamous Cell Carcinoma.

Authors:  Yaoxiang Xu; Yanshan Liu; Wenlin Xiao; Jin Yue; Lingfa Xue; Qunli Guan; Jing Deng; Jian Sun
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.